The invention discloses a use of a diarylamide compound with a structure shown as a formula (I), and a pharmaceutically acceptable salt thereof in the preparation of a medicine serving as a urea transporter inhibitor, and the novel diarylamide compound. T
-
Paragraph 0219-0222; 0231-0234
(2020/12/31)
More Articles about upstream products of 22941-33-9